![Martin Freed](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Martin Freed
Directeur/Membre du Conseil chez
SOLID BIOSCIENCES INC.
Fortune : 26 307 $ au 31/05/2026
Profil
Martin I.
Freed was the founder of Civitas Therapeutics, Inc., founded in 2009, where the title held was Chief Medical Officer from 2010 to 2014.
Current jobs include Independent Director at Solid Biosciences, Inc. since 2018 and Director at Avilar Therapeutics, Inc. Former jobs include Director at InteKrin Therapeutics, Inc. from 2007 to 2010; Independent Director at Dicerna Pharmaceuticals, Inc. from 2016 to 2021; Independent Director at Sojournix, Inc. from 2017 to 2021; Senior Vice President-Clinical Development at Acorda Therapeutics, Inc. from 2014 to 2015; Chief Medical Officer at Taligen Therapeutics, Inc. from 2009 to 2010; Chief Medical Officer at Adnexus from 2007 to 2008; Chief Medical Officer at Vitae Pharmaceuticals LLC from 2005 to 2007; Chief Medical Officer at Avila Therapeutics, Inc. from 2009 to 2011; VP-Clinical Development & Medical Affairs at GlaxoSmithKline LLC; and VP-Clinical Development & Medical Affairs at Smithkline Beecham Pharmaceuticals (Canada) from 1991 to 2005.
Education includes undergraduate degree from the University of Delaware in 1986 and doctorate from Pennsylvania State University College of Medicine in 1986.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 10/06/2026 | 3 584 ( 0 % ) | 26 307 $ | 31/05/2026 |
Postes actifs de Martin Freed
| Sociétés | Poste | Début |
|---|---|---|
| SOLID BIOSCIENCES INC. | Directeur/Membre du Conseil | 26/06/2018 |
Avilar Therapeutics, Inc.
 Avilar Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company which develops covalent drugs to treat cancer and other autoimmune diseases | Directeur/Membre du Conseil | - |
Anciens postes connus de Martin Freed
| Sociétés | Poste | Fin |
|---|---|---|
| DICERNA PHARMACEUTICALS, INC. | Directeur/Membre du Conseil | 28/12/2021 |
Sojournix, Inc.
 Sojournix, Inc. BiotechnologyHealth Technology Operates in the healthcare industry focusing on biotechnology business | Directeur/Membre du Conseil | 01/06/2021 |
| ACORDA THERAPEUTICS, INC. | Corporate Officer/Principal | 01/01/2015 |
Civitas Therapeutics, Inc.
 Civitas Therapeutics, Inc. BiotechnologyHealth Technology Develops transformative pulmonary delivery therapies | Fondateur | 01/10/2014 |
Avila Therapeutics, Inc.
 Avila Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Researches and develops covalent drugs | Directeur Technique/Scientifique/R&D | 01/03/2011 |
Formation de Martin Freed
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
59
Relations au 1er degré
15
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 15 |
|---|---|
Acorda Therapeutics, Inc.
 Acorda Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops neurology therapies | Health Technology |
Taligen Therapeutics, Inc.
 Taligen Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and develops inflammatory disease pharamaceutical products | Health Technology |
InteKrin Therapeutics, Inc.
 InteKrin Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes therapeutics for metabolic and immune disorders | Health Technology |
Dicerna Pharmaceuticals, Inc.
 Dicerna Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that focuses on discovering, developing and commercializing medicines for chronic liver diseases | Health Technology |
Adnexus
 Adnexus Pharmaceuticals: MajorHealth Technology Develops medicines which includes protein antagonists | Health Technology |
University of Delaware
 University of Delaware Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Vitae Pharmaceuticals LLC
 Vitae Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops small molecule compounds | Health Technology |
Avila Therapeutics, Inc.
Avila Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Researches and develops covalent drugs | Health Technology |
GlaxoSmithKline LLC
 GlaxoSmithKline LLC Pharmaceuticals: MajorHealth Technology Engages in research and development, manufacturing of respiratory, immunology, oncology and infectious disease medicines and vaccines | Health Technology |
Civitas Therapeutics, Inc.
Civitas Therapeutics, Inc. BiotechnologyHealth Technology Develops transformative pulmonary delivery therapies | Health Technology |
Smithkline Beecham Pharmaceuticals (Canada) | |
Pennsylvania State University College of Medicine
 Pennsylvania State University College of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sojournix, Inc.
Sojournix, Inc. BiotechnologyHealth Technology Operates in the healthcare industry focusing on biotechnology business | Health Technology |
Solid Biosciences, Inc.
 Solid Biosciences, Inc. BiotechnologyHealth Technology Operates as a pharmaceutical company that develops treatments through gene therapy for patients with duchenne disease | Health Technology |
Avilar Therapeutics, Inc.
Avilar Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company which develops covalent drugs to treat cancer and other autoimmune diseases | Commercial Services |
